- Report
- November 2024
- 150 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 413 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 154 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- July 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- July 2024
- 70 Pages
Europe
From €2685EUR$2,950USD£2,302GBP
- Report
- November 2022
- 295 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- February 2024
- 255 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- June 2022
- 283 Pages
United States
From €2389EUR$2,625USD£2,048GBP
€4778EUR$5,250USD£4,096GBP
- Report
- March 2021
- 216 Pages
Global
From €1251EUR$1,375USD£1,073GBP
€2503EUR$2,750USD£2,146GBP
- Report
- November 2022
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- February 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2022
- 101 Pages
North America
From €1365EUR$1,500USD£1,170GBP
- Report
- July 2023
- 96 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2023
- 112 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2021
- 1032 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Book
- March 2010
- 784 Pages

Molecular biomarkers are molecules that can be used to identify and measure biological processes, such as disease states or drug responses. They are used in a variety of applications, including diagnostics, drug development, and personalized medicine. Molecular biomarkers are typically proteins, nucleic acids, or metabolites that can be measured in a variety of biological samples, such as blood, urine, or tissue.
The molecular biomarker market is a rapidly growing segment of the larger biomarker market. It is driven by advances in technology, such as next-generation sequencing and mass spectrometry, which have enabled the identification and quantification of molecular biomarkers with greater accuracy and sensitivity. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are driving the demand for molecular biomarkers.
Some companies in the molecular biomarker market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more